PET imaging of glucose and fatty acid metabolism for NAFLD patients.
作者信息
Gullberg Grant T, Shrestha Uttam M, Seo Youngho
机构信息
Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.
出版信息
J Nucl Cardiol. 2020 Oct;27(5):1689-1697. doi: 10.1007/s12350-018-01532-8. Epub 2018 Dec 13.
Abstract
摘要
相似文献
1
PET imaging of glucose and fatty acid metabolism for NAFLD patients.
J Nucl Cardiol. 2020 Oct;27(5):1689-1697. doi: 10.1007/s12350-018-01532-8. Epub 2018 Dec 13.
2
Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by F-fluorodeoxyglucose positron emission tomography.
J Nucl Cardiol. 2020 Oct;27(5):1679-1688. doi: 10.1007/s12350-018-1446-x. Epub 2018 Sep 20.
3
Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
J Hepatol. 2018 Apr;68(4):764-772. doi: 10.1016/j.jhep.2017.11.023. Epub 2017 Nov 24.
4
Association between vascular inflammation and non-alcoholic fatty liver disease: Analysis by F-fluorodeoxyglucose positron emission tomography.
Metabolism. 2017 Feb;67:72-79. doi: 10.1016/j.metabol.2016.11.004. Epub 2016 Nov 6.
5
FDG PET/CT of the non-malignant liver in an increasingly obese world population.
Clin Physiol Funct Imaging. 2020 Sep;40(5):304-319. doi: 10.1111/cpf.12651. Epub 2020 Jul 15.
6
Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis.
J Nucl Cardiol. 2021 Apr;28(2):610-620. doi: 10.1007/s12350-019-01736-6. Epub 2019 May 10.
7
Hepatic FDG uptake is associated with future cardiovascular events in asymptomatic individuals with non-alcoholic fatty liver disease.
J Nucl Cardiol. 2017 Jun;24(3):892-899. doi: 10.1007/s12350-015-0297-y. Epub 2015 Oct 28.
8
Association between nonalcoholic fatty liver disease and carotid artery inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography.
Angiology. 2015 May;66(5):472-80. doi: 10.1177/0003319714537872. Epub 2014 Jun 5.
9
Novel approach using [F]FTHA-PET and de novo synthesized VLDL for assessment of FFA metabolism in a rat model of diet induced NAFLD.
Clin Nutr. 2023 Oct;42(10):1839-1848. doi: 10.1016/j.clnu.2023.08.001. Epub 2023 Aug 8.
10
Dynamic Positron Emission Tomography/Computed Tomography Imaging Correlate of Nonalcoholic Steatohepatitis.
Clin Gastroenterol Hepatol. 2021 Nov;19(11):2441-2443. doi: 10.1016/j.cgh.2020.10.029. Epub 2020 Oct 17.
引用本文的文献
1
Non-Alcoholic Fatty Liver Disease and Echocardiographic Parameters of Left Ventricular Diastolic Function: A Systematic Review and Meta-Analysis.
Int J Mol Sci. 2023 Sep 19;24(18):14292. doi: 10.3390/ijms241814292.
2
Heart Uptake of [F]Fluoro-4-Thia-Oleate in a Non-Alcoholic Fatty Liver Disease Mouse Model.
Pharmaceuticals (Basel). 2022 Dec 17;15(12):1577. doi: 10.3390/ph15121577.
3
Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation.
Cell Biosci. 2022 Jun 28;12(1):99. doi: 10.1186/s13578-022-00836-0.
4
Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2020: positron emission tomography, computed tomography, and magnetic resonance.
J Nucl Cardiol. 2021 Oct;28(5):2100-2111. doi: 10.1007/s12350-021-02685-9. Epub 2021 Jun 8.
5
Molecular Imaging of Inflammatory Disease.
Biomedicines. 2021 Feb 4;9(2):152. doi: 10.3390/biomedicines9020152.
本文引用的文献
1
Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression.
J Lipid Res. 2018 Oct;59(10):1977-1986. doi: 10.1194/jlr.M085613. Epub 2018 Jul 24.
2
Repeatable and reproducible measurements of myocardial oxidative metabolism, blood flow and external efficiency using C-acetate PET.
J Nucl Cardiol. 2018 Dec;25(6):1912-1925. doi: 10.1007/s12350-018-1206-y. Epub 2018 Feb 16.
3
Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism.
Sci Transl Med. 2018 Feb 7;10(427). doi: 10.1126/scitranslmed.aao0144.
4
Metabolomic Analysis in Heart Failure.
Circ J. 2017 Dec 25;82(1):10-16. doi: 10.1253/circj.CJ-17-1184. Epub 2017 Dec 8.
5
Radiopharmaceutical tracers for cardiac imaging.
J Nucl Cardiol. 2018 Aug;25(4):1204-1236. doi: 10.1007/s12350-017-1131-5. Epub 2017 Dec 1.
6
Development of C-Labeled ω-sulfhydryl fatty acid tracer for myocardial imaging with PET.
Eur J Med Chem. 2018 Jan 1;143:1657-1666. doi: 10.1016/j.ejmech.2017.10.062. Epub 2017 Oct 23.
7
Genetics and epigenetics of NAFLD and NASH: Clinical impact.
J Hepatol. 2018 Feb;68(2):268-279. doi: 10.1016/j.jhep.2017.09.003. Epub 2017 Nov 6.
8
Liver disease and heart failure: Back and forth.
Eur J Intern Med. 2018 Feb;48:25-34. doi: 10.1016/j.ejim.2017.10.016.
9
Longitudinal Evaluation of Myocardial Fatty Acid and Glucose Metabolism in Fasted and Nonfasted Spontaneously Hypertensive Rats Using MicroPET/CT.
Mol Imaging. 2017 Jan-Dec;16:1536012117724558. doi: 10.1177/1536012117724558.
10
Mitochondrial-Targeted Molecular Imaging in Cardiac Disease.
Biomed Res Int. 2017;2017:5246853. doi: 10.1155/2017/5246853. Epub 2017 May 30.
Zotero 插件